UPDATE 1-Celgene to invest $1 bln in Juno to partner in cancer therapies
June 29, 2015 at 17:32 PM EDT
June 29 (Reuters) - Celgene Corp said it would invest about $1 billion in Juno Therapeutics Inc to partner in the development and marketing of immunotherapies for the treatment of cancer and autoimmune diseases.
